AP NEWS

Illumina to Announce Third Quarter 2018 Financial Results on Tuesday, October 23, 2018

October 9, 2018

SAN DIEGO--(BUSINESS WIRE)--Oct 9, 2018--Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for third quarter 2018 following the close of market on Tuesday, October 23, 2018.

On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Francis deSouza, President and Chief Executive Officer, and Sam Samad, Senior Vice President and Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Tuesday, October 23, 2018. Interested parties may access the live teleconference through the Investor Relations section of Illumina’s web site under the “company” tab at www.illumina.com. Alternatively, individuals can access the call by dialing 1-800-708-4540, or 1-847-619-6397 outside North America, both with passcode 47554920.

A replay of the conference call will be available from 4:30 pm Pacific Time (7:30 pm Eastern Time) on October 23, 2018 through October 30, 2018 by dialing 1-888-843-7419, or 1-630-652-3042 outside North America, both with passcode 47554920.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit  www.illumina.com  and follow @illumina.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181009006043/en/

CONTACT: Illumina, Inc.

Investors:

Jacquie Ross, CFA

858-882-2172

ir@illumina.com

or

Media:

Eric Endicott

858-882-6822

pr@illumina.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: HEALTH AIDS BIOTECHNOLOGY CARDIOLOGY CLINICAL TRIALS GENETICS INFECTIOUS DISEASES MEDICAL DEVICES ONCOLOGY PHARMACEUTICAL OTHER HEALTH NATURAL RESOURCES AGRICULTURE BABY/MATERNITY RESEARCH CONSUMER SCIENCE

SOURCE: Illumina, Inc.

Copyright Business Wire 2018.

PUB: 10/09/2018 04:30 PM/DISC: 10/09/2018 04:30 PM

http://www.businesswire.com/news/home/20181009006043/en

AP RADIO
Update hourly